申请人:Bartkovitz Joseph David
公开号:US20070060607A1
公开(公告)日:2007-03-15
The present invention relates to compounds of the formula
medicaments containing them and the use of these compounds as pharmaceutically active agents. The compounds exhibit activity as Raf kinase inhibitors and therefore may be useful for the treatment of diseases mediated by said kinases, especially as anticancer agents.
本发明涉及公式化合物、含有它们的药物以及将这些化合物用作药用活性剂的用途。这些化合物表现出作为Raf激酶抑制剂的活性,因此可能对通过该激酶介导的疾病的治疗有用,特别是作为抗癌剂。